| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/08/2011 | EP2329025A1 Periostin-induced pancreatic regeneration |
| 06/08/2011 | EP2329023A1 Compositions and methods for delivery of protein-coding rnas to correct mitochondrial dysfunction |
| 06/08/2011 | EP2328570A2 Method and formulation for treating adverse biological conditions |
| 06/08/2011 | EP1954811B1 Inducible expression systems |
| 06/08/2011 | EP1766013B1 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 06/08/2011 | EP1619949B1 Postnatal stem cells and uses thereof |
| 06/08/2011 | EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
| 06/08/2011 | EP1502599B1 Use of mutated VEGF for antiangiogenic therapy |
| 06/08/2011 | EP1276500B1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2 |
| 06/08/2011 | EP1078093B1 Vaccines, immunotherapeutics and methods for using the same |
| 06/08/2011 | EP1069821B1 Method of controlling proliferation and differentiation of stem and progenitor cells |
| 06/08/2011 | EP0914142B1 Peptides with increased binding affinity for at least three hla-a3-like molecules |
| 06/08/2011 | CN1927877B siRNA for inhibiting human Ezrin gene expression and expression vector thereof |
| 06/08/2011 | CN102089003A Recombinant rhinovirus vectors |
| 06/08/2011 | CN102089001A Immunity-inducing agent and method for detection of cancer |
| 06/08/2011 | CN102086453A Tumor DNA vaccine taking mucin 1 and survivin as targets and viral vector vaccine |
| 06/08/2011 | CN102086266A Polypeptide-containing asymmetric hyperbranched amphoteric polyelectrolyte and preparation method thereof |
| 06/08/2011 | CN102085378A Application of hfgl2 (Human Fibrinogen-like protein 2) inhibitor in preparation of medicaments for treating liver cancer |
| 06/08/2011 | CN102085377A Immunogenic composition and methods |
| 06/08/2011 | CN101632836B DNA vaccine for Edwardsiella tarda and construction and application thereof |
| 06/08/2011 | CN101200721B Human myocardium protecting gene and uses thereof |
| 06/08/2011 | CN101035835B Biodegradable cationic polymers |
| 06/08/2011 | CN101031645B 神经再生 Nerve regeneration |
| 06/07/2011 | US7956176 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| 06/07/2011 | US7956038 GASP1: a follistatin domain containing protein |
| 06/07/2011 | US7955849 Method of enriching a mammalian cell population for mesoderm cells |
| 06/07/2011 | US7955844 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals |
| 06/07/2011 | US7955600 Attenuated salmonella SP12 mutants as antigen carriers |
| 06/07/2011 | US7955595 Glutamic acid decarboxylase (GAD) based delivery system |
| 06/07/2011 | CA2571318C Nerve regeneration by transplanting cells expressing recombinant transforming growth factor superfamily protein |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2442971C Chemotherapeutic induction of egr-1 promoter activity |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2349838C Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 06/03/2011 | WO2011066511A1 Synthetic apoa-1 mimetic amphipathic peptides and methods of use thereof |
| 06/03/2011 | WO2011063455A1 Modulation of epidermal growth factor receptor ligands |
| 06/03/2011 | WO2011017315A3 Methods and compositions for targeted gene modification |
| 06/03/2011 | WO2010140834A3 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |
| 06/03/2011 | CA2781571A1 Modulation of epidermal growth factor receptor ligands |
| 06/02/2011 | US20110130340 Methods of identifying anti-cancer agents and uses thereof |
| 06/02/2011 | US20110130301 Settings for recombinant adenoviral-based vaccines |
| 06/02/2011 | US20110129883 Inactivation of genes of the mep pathway |
| 06/02/2011 | US20110129534 Reduction of dermal scarring |
| 06/02/2011 | US20110129511 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 06/02/2011 | US20110129482 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 06/02/2011 | US20110129466 Methods of treating cancer by administering antibodies to cd200 |
| 06/02/2011 | US20110129465 Mammalian Receptor Proteins; Related Reagents and Methods |
| 06/02/2011 | US20110129449 Compensating for atrioventricular block using a nucleic acid encoding a sodium channel or gap junction protein |
| 06/01/2011 | EP2327784A2 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 06/01/2011 | EP2327779A1 New therapeutic agent for malignant mesothelioma and immunostimulant |
| 06/01/2011 | EP2327775A2 Therapy for alpha-galactosidase a deficiency |
| 06/01/2011 | EP2327710A1 Anti-microRNA oligonucleotide molecules |
| 06/01/2011 | EP2327709A2 Modulation of glucagon receptor expression |
| 06/01/2011 | EP2327422A1 Activin antagonists for diagnosis and therapy of diseases associated with fibrosis |
| 06/01/2011 | EP2327417A2 Identification of surface-associated antigens for tumour diagnosis and therapy |
| 06/01/2011 | EP2326318A2 Sur1 inhibitors for therapy |
| 06/01/2011 | EP1786474B1 Combined gene therapy for the treatment of macroscopic gliomas |
| 06/01/2011 | EP1785484B1 Oligonucleotide inhibiting tumor cell proliferation and method therefor |
| 06/01/2011 | EP1354946B1 Bhlh-pas proteins, genes thereof and utilization of the same |
| 06/01/2011 | EP1259265B1 Nucleic acid formulations for gene delivery |
| 06/01/2011 | EP1073759B1 Recombinant virus expressing foreign dna encoding feline cd80, feline cd28, feline ctla-4 or feline cd86 and uses thereof |
| 06/01/2011 | CN102083980A Micro-RNAs that modulate smooth muscle proliferation and differentiation and uses thereof |
| 06/01/2011 | CN102083972A Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 06/01/2011 | CN102083878A Diblock copolymers and polynucleotide complexes thereof for delivery into cells |
| 06/01/2011 | CN102083462A Lentiviral gene transfer vectors and their medicinal applications |
| 06/01/2011 | CN102083419A Pharmaceutical composition containing surface-coated microparticles |
| 06/01/2011 | CN102080098A Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation |
| 06/01/2011 | CN102079787A Antihuman CD52 engineering antibody, carrier, kit and application thereof |
| 06/01/2011 | CN102079780A Construction of recin A chain mutant and application of recin A chain mutant as candidate vaccine antigen |
| 06/01/2011 | CN102078622A Bacterial delivery system |
| 06/01/2011 | CN102078621A Method and composition of regulating and controlling plasmacytoid dendritic cell I type interferon expression |
| 06/01/2011 | CN102078607A Preparation and application of recombinant adenovirus vector bivalent living vaccine for herpes progenitalis |
| 06/01/2011 | CN101338302B Recombination herpes simplex virus for tumor gene therapy |
| 05/31/2011 | US7951919 TACI-immunoglobulin fusion proteins |
| 05/31/2011 | US7951907 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 05/31/2011 | US7951786 Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides |
| 05/31/2011 | US7951783 Therapeutically useful molecules |
| 05/31/2011 | US7951775 Methods and pharmaceutical compositions for GnRH-I and GnRH-II modulation of T-cell activity, adhesion, migration and extravasation |
| 05/31/2011 | US7951614 Methods and compositions for the production of monoclonal antibodies |
| 05/31/2011 | US7951586 DNA sequences comprising gene transcription regulatory qualities and methods for detecting and using such DNA sequences |
| 05/31/2011 | US7951585 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor GM-CSF in tumor cells and uses thereof |
| 05/31/2011 | US7951532 Modulating mammalian midkine activity; alters pulmonary vasculature development and smooth muscle cell development |
| 05/31/2011 | US7951386 Recombinant cytochrome oxidase and/or morula membrane protein for use in developing therapeutics which prevent infection associated with mite parasitfes |
| 05/31/2011 | US7951381 Method of stimulating epithelial cell proliferation by administration of gastrointestinal proliferative factor |
| 05/31/2011 | US7951379 Hollow nanoparticle of NBsAg large protein for drug delivery |
| 05/31/2011 | US7951375 Methods of inducing an immune response |
| 05/31/2011 | US7951373 Administering to mammal a neural growth and/or remyelination and/or neuroprotection promoting amount of an agent comprising a neural cell adhesion molecule, which molecule is capable of overcoming inhibitory molecular cues found on glial cells |
| 05/31/2011 | US7951362 Compositions and methods of use of targeting peptides against placenta and adipose tissues |
| 05/31/2011 | US7951361 Transgenic escherichia for which express bacterial surface protein for use in generation of vaccine which prevents coliform bacterial infection; antidiarrhea agents |
| 05/31/2011 | CA2451626C One dose vaccination with mycoplasma hyopneumoniae |
| 05/31/2011 | CA2398539C Myeloid colony stimulating factor and uses thereof |
| 05/31/2011 | CA2339324C Protein delivery system using human papillomavirus virus-like particles |
| 05/31/2011 | CA2321903C Live recombinant vaccines comprising an adjuvant compound and a viral vector comprising a gene of an animal herpes or influenza virus |
| 05/31/2011 | CA2292922C Process for inactivating enveloped viruses in a viral preparation of non-enveloped viruses |
| 05/31/2011 | CA2237356C Methods for diagnosis and treatment of bloom's syndrome |
| 05/26/2011 | WO2011062962A2 Smndelta7 degron: novel compositions and methods of use |
| 05/26/2011 | WO2011062298A1 System for increasing gene expression, and vector supporting said system |
| 05/26/2011 | WO2011062155A1 NUCLEIC ACID ENCODING MUTANT Gag PROTEIN |
| 05/26/2011 | WO2010135329A3 Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor |